A detailed history of State Street Corp transactions in Voyager Therapeutics, Inc. stock. As of the latest transaction made, State Street Corp holds 1,789,189 shares of VYGR stock, worth $12.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,789,189
Previous 1,749,168 2.29%
Holding current value
$12.5 Million
Previous $16.3 Million 13.09%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$7.42 - $10.54 $296,955 - $421,821
40,021 Added 2.29%
1,789,189 $14.2 Million
Q1 2024

May 15, 2024

BUY
$7.15 - $10.84 $8.07 Million - $12.2 Million
1,129,356 Added 182.21%
1,749,168 $16.3 Million
Q4 2023

Feb 14, 2024

BUY
$6.28 - $8.81 $236,021 - $331,106
37,583 Added 6.46%
619,812 $5.23 Million
Q3 2023

Nov 14, 2023

BUY
$7.55 - $11.25 $282,105 - $420,356
37,365 Added 6.86%
582,229 $4.51 Million
Q2 2023

Aug 14, 2023

BUY
$6.94 - $13.99 $3.13 Million - $6.31 Million
450,767 Added 479.05%
544,864 $6.24 Million
Q1 2023

May 15, 2023

BUY
$6.0 - $10.78 $31,800 - $57,134
5,300 Added 5.97%
94,097 $725,000
Q2 2022

Aug 15, 2022

SELL
$4.82 - $10.09 $22,172 - $46,414
-4,600 Reduced 4.93%
88,797 $525,000
Q1 2022

May 16, 2022

BUY
$2.75 - $9.44 $23,603 - $81,023
8,583 Added 10.12%
93,397 $712,000
Q2 2021

Aug 16, 2021

SELL
$3.94 - $5.44 $1.6 Million - $2.21 Million
-405,656 Reduced 82.71%
84,814 $350,000
Q1 2021

May 17, 2021

SELL
$4.61 - $9.04 $296,930 - $582,266
-64,410 Reduced 11.61%
490,470 $2.31 Million
Q4 2020

Feb 16, 2021

SELL
$7.15 - $12.28 $83,504 - $143,418
-11,679 Reduced 2.06%
554,880 $3.97 Million
Q3 2020

Nov 10, 2020

SELL
$10.01 - $13.75 $7.16 Million - $9.84 Million
-715,307 Reduced 55.8%
566,559 $6.05 Million
Q2 2020

Aug 14, 2020

SELL
$8.05 - $14.21 $706,661 - $1.25 Million
-87,784 Reduced 6.41%
1,281,866 $16.2 Million
Q1 2020

May 11, 2020

BUY
$6.8 - $14.66 $9.31 Million - $20.1 Million
1,369,650 New
1,369,650 $12.5 Million

Others Institutions Holding VYGR

About Voyager Therapeutics, Inc.


  • Ticker VYGR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,647,600
  • Market Cap $271M
  • Description
  • Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...
More about VYGR
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.